Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit

Autor: Karlsson, A., Ellonen, A., Irjala, H., Väliaho, V., Mattila, K., Nissi, L., Kytö, E., Kurki, S., Ristamäki, R., Vihinen, P., Laitinen, T., Ålgars, A., Jyrkkiö, S., Minn, H., Heervä, E.

Publikováno v: In ESMO Open June 2021 6(3)

Restoring mechanophenotype reverts malignant properties of ECM-enriched vocal fold cancer.

Autor: Kaivola J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Punovuori K; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki Finland., Chastney MR; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Miroshnikova YA; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki Finland.; Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Abdo H; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy., Bertillot F; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki Finland.; Department of Cell and Tissue Dynamics, Max Planck Institute for Molecular Biomedicine, Münster, Germany., Krautgasser F; Faculty of Physics, University of Vienna, Vienna, Austria., Franco JD; Faculty of Physics, University of Vienna, Vienna, Austria.; Vienna Doctoral School in Physics, University of Vienna, Vienna, Austria., Conway JRW; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Follain G; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Hagström J; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Department of Oral Pathology and Radiology, University of Turku and Turku University Hospital, Turku, Finland.; Research Programs Unit, Translational Cancer Medicine, University of Helsinki, Helsinki, Finland., Mäkitie A; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden., Irjala H; Department of Otorhinolaryngology-Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Ventelä S; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; Department of Otorhinolaryngology-Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Hamidi H; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Scita G; Department of Cell and Tissue Dynamics, Max Planck Institute for Molecular Biomedicine, Münster, Germany.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Cerbino R; Faculty of Physics, University of Vienna, Vienna, Austria., Wickström SA; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki Finland.; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.; Helsinki Institute of Life Science, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.; Wihuri Research Institute, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Ivaska J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; Department of Life Technologies, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.; Foundation for the Finnish Cancer Institute, Helsinki, Finland.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.

Correction to: Programmed death-ligand 1 and tumor-infiltrating lymphocytes (TILs) - low TIL density may predict poorer long-term prognosis in T1 laryngeal cancer.

Autor: Pakkanen P; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. pihla.pakkanen@helsinki.fi., Ilmarinen T; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Halme E; Department of Otorhinolaryngology - Head and Neck Surgery, University of Tampere and Tampere University Hospital, Tampere, Finland., Irjala H; Department of Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Koivunen P; Department of Otorhinolaryngology - Head and Neck Surgery, University of Oulu and Oulu University Hospital, Oulu, Finland., Pukkila M; Department of Otorhinolaryngology - Head and Neck Surgery, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland., Ventelä S; Department of Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland., Almangush A; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Birkman EM; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland., Lindgren O; Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland., Pohjolainen V; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland., Sjöblom N; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Haglund C; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Hagström J; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Oral Pathology and Radiology, University of Turku, Turku, Finland., Aaltonen LM; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Aug; Vol. 485 (2), pp. 383-384.

Psychosocial factors and patient and healthcare delays in large (class T3-T4) oral, oropharyngeal, and laryngeal carcinomas.

Autor: Atula M; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, Helsinki University Hospital, P.O.Box 263, Helsinki, HUS, FI-00029, Finland. markus.f.nieminen@helsinki.fi., Atula T; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, Helsinki University Hospital, P.O.Box 263, Helsinki, HUS, FI-00029, Finland., Aro K; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, Helsinki University Hospital, P.O.Box 263, Helsinki, HUS, FI-00029, Finland., Irjala H; Department of Otorhinolaryngology-Head and Neck Surgery, Turku University Hospital, University of Turku, Turku, Finland., Halme E; Department of Otorhinolaryngology-Head and Neck Surgery, Tampere University Hospital, University of Tampere, Tampere, Finland., Jouppila-Mättö A; Department of Otorhinolaryngology-Head and Neck Surgery, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland., Koivunen P; Department of Otorhinolaryngology-Head and Neck Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.; PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Medical Research Center Oulu, Oulu, Finland., Wilkman T; Department of Oral and Maxillofacial Surgery, University of Helsinki, Helsinki University Hospital, Helsinki, Finland., Mäkitie A; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, Helsinki University Hospital, P.O.Box 263, Helsinki, HUS, FI-00029, Finland.; Department of Clinical Sciences, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Elovainio M; Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Finnish Institute for Health and Welfare, Helsinki, Finland., Pulkki-Råback L; Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Publikováno v: BMC cancer [BMC Cancer] 2024 Jun 25; Vol. 24 (1), pp. 760. Date of Electronic Publication: 2024 Jun 25.

TSPO is a potential independent prognostic factor associated with cellular respiration and p16 in head and neck squamous cell carcinoma.

Autor: Tuominen S; Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Turku, Finland.; Cancer Research Unit, Institute of Biomedicine, University of Turku, Turku, Finland.; FICAN West Cancer Research Laboratory, Turku University Hospital and University of Turku, Turku, Finland.; Medicity Research Laboratory, Faculty of Medicine, University of Turku, Turku, Finland., Nissi L; Department of Clinical Oncology, Turku University Hospital and University of Turku, Turku, Finland., Kukkula A; Cancer Research Unit, Institute of Biomedicine, University of Turku, Turku, Finland.; FICAN West Cancer Research Laboratory, Turku University Hospital and University of Turku, Turku, Finland., Routila J; Department of Otorhinolaryngology - Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland., Huusko T; Department of Otorhinolaryngology - Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland., Leivo I; Department of Pathology, Turku University Hospital and University of Turku, Turku, Finland., Minn H; Department of Clinical Oncology, Turku University Hospital and University of Turku, Turku, Finland., Irjala H; Department of Otorhinolaryngology - Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland., Löyttyniemi E; Department of Biostatistics, Turku University Hospital and University of Turku, Turku, Finland., Ventelä S; Department of Otorhinolaryngology - Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland., Sundvall M; Cancer Research Unit, Institute of Biomedicine, University of Turku, Turku, Finland.; FICAN West Cancer Research Laboratory, Turku University Hospital and University of Turku, Turku, Finland.; Department of Clinical Oncology, Turku University Hospital and University of Turku, Turku, Finland., Grönroos TJ; Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Turku, Finland.; Medicity Research Laboratory, Faculty of Medicine, University of Turku, Turku, Finland.; Department of Clinical Oncology, Turku University Hospital and University of Turku, Turku, Finland.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Dec 14; Vol. 13, pp. 1298333. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).